Veradermics MANE
NYSE MANE
$127.10 +4.82 (+3.94%)
As of: Oct 20, 2026 · 3:59 PM EDT

Veradermics (MANE) Operating Income (2025 - 2026)

Updated

Veradermics' Operating Income came in at -$29.55 million for Q2 2026, compared with -$16.07 million a year earlier.

Analysis

Veradermics (MANE) Operating Income (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Veradermics reported Operating Income of -$88.4 million; for FY2025, it came in at -$72.35 million.

  • Going back by year, Operating Income was -$26.78 million in FY2024.
  • The five-year range for quarterly Operating Income is -$29.86 million (Q1 2026) to -$12.92 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 7.14 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 6.43 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 3.16 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -10.39 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 4.27 Bn
10 Veradermics 5.17 Bn 3.77 Bn - -29.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -29.55 Mn
Mar 31, 2026 -29.86 Mn
Jun 30, 2025 -16.07 Mn
Mar 31, 2025 -12.92 Mn
API Access

Veradermics Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=MANE&period=max&api_key=YOUR_API_KEY